Symrise Overview
- Year Founded
-
1873

- Status
-
Public
- Employees
-
12,538

- Stock Symbol
-
SY1

- Investments
-
48
- Share Price
-
$99.57
- (As of Thursday Closing)
Symrise General Information
Description
Symrise is a global supplier of ingredients for fragrances and flavourings across the food, beverage, household products, and pharmaceutical industries. With an estimated 12% market share, it is the world's fourth-largest supplier of fragrances and flavourings. The company was created after a 2003 merger of two companies that originated in 1874 and 1919. With 9,000 employees, Symrise produces 30,000 products sourced from 10,000 mostly natural raw materials such as vanilla, citrus, blossoms, and plant or animal materials for more than 6,000 customers.
Contact Information
Website
www.symrise.comCorporate Office
- Mühlenfeldstrasse 1
- 37603 Holzminden
- Germany
Corporate Office
- Mühlenfeldstrasse 1
- 37603 Holzminden
- Germany
Symrise Stock Performance
As of 27-Mar-2025, Symrise’s stock price is $99.57. Its current market cap is $13.9B.
(As of Thursday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$99.57 | $97.04 | $95.53 - $139.20 | $13.9B | 339K | $3.04 |
Symrise Financials Summary
As of 30-Jun-2024, Symrise has a trailing 12-month revenue of $5.28B.
In Thousands, USD |
TTM 30-Jun-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
---|---|---|---|---|
EV | 19,561,870 | 18,114,463 | 17,479,240 | 22,433,399 |
Revenue | 5,281,662 | 5,118,419 | 4,855,880 | 4,523,109 |
EBITDA | 996,570 | 902,618 | 812,417 | 951,921 |
Net Income | 424,532 | 368,417 | 294,400 | 443,272 |
Total Assets | 8,480,204 | 8,672,540 | 8,346,431 | 7,555,521 |
Total Debt | 2,736,621 | 2,828,356 | 2,731,842 | 2,038,820 |
Symrise Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Symrise Comparisons
Industry
Financing
Details
Symrise Competitors (25)
One of Symrise’s 25 competitors is Döhler, a Private Debt Financed company based in Darmstadt, Germany.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Döhler | Private Debt Financed | Darmstadt, Germany | ||||
PureCircle | Corporate Backed or Acquired | Westchester, IL | ||||
Takasago International | Corporation | Tokyo, Japan | ||||
CovationBio | PDO | Formerly PE-Backed | Loudon, TN | ||||
Bell Flavors & Fragrances | Corporation | Northbrook, IL |
Symrise Patents
Symrise Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
DE-202024104036-U1 | Advantageous forms of 4'-hydroxyacetophenone | Active | 19-Jul-2024 | ||
EP-4527191-A1 | Urease inhibitors | Pending | 20-Sep-2023 | ||
FR-3152024-A1 | New fragrance substances and their uses | Pending | 08-Aug-2023 | ||
EP-4416138-A1 | Novel derivatives of glycerol | Pending | 30-May-2023 | ||
EP-4526411-A1 | Fragrance compositions and products conveying a positive mood | Pending | 17-May-2023 |
Symrise Signals
Symrise Investments & Acquisitions (48)
Symrise’s most recent deal was a Secondary Transaction - Open Market with Probi for . The deal was made on 20-Nov-2024.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Probi | 20-Nov-2024 | Secondary Transaction - Open Market | Biotechnology | ||
Bonumose | 10-Oct-2024 | Later Stage VC | Other Commercial Products | ||
Vizag Care Ingredients | 28-Mar-2024 | Joint Venture | Personal Products | ||
Kobo Products | 05-Oct-2023 | Corporate | Specialty Chemicals | ||
Swedencare | 25-May-2023 | PIPE | Other Pharmaceuticals and Biotechnology |
Symrise ESG
Risk Overview
Risk Rating
Updated May, 31, 2024
18.01 | Low Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,946
Rank
Percentile

Chemicals
Industry
of 580
Rank
Percentile

Specialty Chemicals
Subindustry
of 144
Rank
Percentile

Symrise Exits (4)
Symrise’s most recent exit was on 01-Mar-2019 from Phlur. The exit was categorized as with 3 buyers.
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
Phlur | 01-Mar-2019 | Completed |
|
||
Phlur | 19-Mar-2018 | Completed |
|
||
Pinova (Specialty Chemicals) | 07-Jan-2016 | Completed |
|
||
Flavor Infusion International | 05-Jun-2015 | Merger/Acquisition | Completed |
Symrise Affiliates
Subsidiaries (15)
Name | Industry | Location | Year Founded |
---|---|---|---|
Wing Pet Food | Shanghai, China | 2007 | |
Symotion | Holzminden, Germany | 2006 | |
Tesium | Holzminden, Germany | 2006 | |
Symrise (Aqua Feed Business) | Brittany, France | 2006 | |
Cutech | Padua, Italy | 2002 |
Symrise FAQs
-
When was Symrise founded?
Symrise was founded in 1873.
-
Where is Symrise headquartered?
Symrise is headquartered in Holzminden, Germany.
-
What is the size of Symrise?
Symrise has 12,538 total employees.
-
What industry is Symrise in?
Symrise’s primary industry is Specialty Chemicals.
-
Is Symrise a private or public company?
Symrise is a Public company.
-
What is Symrise’s stock symbol?
The ticker symbol for Symrise is SY1.
-
What is the current stock price of Symrise?
As of 27-Mar-2025 the stock price of Symrise is $99.57.
-
What is the current market cap of Symrise?
The current market capitalization of Symrise is $13.9B.
-
What is Symrise’s current revenue?
The trailing twelve month revenue for Symrise is $5.28B.
-
Who are Symrise’s competitors?
Döhler, PureCircle, Takasago International, CovationBio | PDO, and Bell Flavors & Fragrances are some of the 25 competitors of Symrise.
-
What is Symrise’s annual earnings per share (EPS)?
Symrise’s EPS for 12 months was $3.04.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »